{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,6]],"date-time":"2026-07-06T08:18:54Z","timestamp":1783325934918,"version":"3.54.6"},"reference-count":0,"publisher":"Bentham Science Publishers Ltd.","content-domain":{"domain":["eurekaselect.com"],"crossmark-restriction":true},"short-container-title":["CPD"],"published-print":{"date-parts":[[2026,7,2]]},"abstract":"<jats:sec>\n                    <jats:title\/>\n                    <jats:p>Topical dosage forms are widely used to treat various skin disorders, but increase healthcare costs\nbecause of the limited number of generic competitors. The development of a generic version of complex topical\nproducts is facing several scientific and regulatory challenges related to demonstrating bioequivalence, advanced\nphysicochemical characterization, and the requirement of clinical endpoint equivalence. This narrative\nreview explores the contemporary scientific and regulatory approaches used for BE assessment of topical generics,\nwith a greater focus on in vitro alternatives and Q3 microstructural characterization. The integration of\nquality by design principles can support the development of robust Q3-based BE strategies. Key in vitro tools\nsuch as IVRT, IVPT, and dermal PBPK modeling are emerging approaches for identifying scientific parameters\nfor regulatory acceptability and overcoming these methodological challenges. Case studies involving bifonazole,\nacyclovir, clotrimazole, and innovative vehicles such as Recura illustrate the practical challenges of\nexisting regulatory frameworks and the increasing use of in vitro and Q3-based approaches. This review highlights\nthe critical gaps in harmonizing global regulatory requirements and underscores the need to foster early\nregulatory engagement and standardize methodological protocols. Together, these initiatives pave the way for\na more predictable, scientifically sound, and cost-effective regulatory environment. This transformation is essential\nfor improving access, reducing development timelines, and advancing the future of topical generic\nmedicines.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.2174\/0113816128475390260619035602","type":"journal-article","created":{"date-parts":[[2026,7,6]],"date-time":"2026-07-06T07:58:36Z","timestamp":1783324716000},"update-policy":"https:\/\/doi.org\/10.2174\/bsp_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Addressing Challenges, Regulatory Shifts, and the Need for Cost-Effective\nAlternatives for Complex Topical Formulations"],"prefix":"10.2174","volume":"32","author":[{"given":"Amatha","family":"Sreedevi","sequence":"first","affiliation":[{"name":"Department of Pharmaceutical Regulatory Affairs and Management, Manipal College of Pharmaceutical Sciences, ManipalAcademy of Higher Education, Manipal, 576104, Karnataka State, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S Smitha","family":"Prabhu","sequence":"additional","affiliation":[{"name":"Department of Dermatology, Venereology and Leprosy,Kasturba Medical College, Manipal Academy of Higher Education, Manipal, 576104, Karnataka State, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Virendra S.","family":"Ligade","sequence":"additional","affiliation":[{"name":"Department of Pharmaceutical Regulatory Affairs and Management, Manipal College of Pharmaceutical Sciences, ManipalAcademy of Higher Education, Manipal, 576104, Karnataka State, India"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"965","container-title":["Current Pharmaceutical Design"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.eurekaselect.com\/article\/download?doi=10.2174\/0113816128475390260619035602","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.eurekaselect.com\/255741\/article","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.eurekaselect.com\/article\/download?doi=10.2174\/0113816128475390260619035602","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,6]],"date-time":"2026-07-06T07:58:49Z","timestamp":1783324729000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.eurekaselect.com\/255741\/article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,2]]},"references-count":0,"alternative-id":["LiveAll1"],"URL":"https:\/\/doi.org\/10.2174\/0113816128475390260619035602","relation":{},"ISSN":["1381-6128"],"issn-type":[{"value":"1381-6128","type":"print"}],"subject":[],"published":{"date-parts":[[2026,7,2]]},"assertion":[{"value":"Peer Reviewed","order":0,"name":"review_status","label":"Review Status","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Double blind","order":1,"name":"review_process","label":"Review Process","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Checked with iThenticate","order":0,"name":"screening_status","label":"Screening Status","group":{"name":"plagiarism_screening","label":"Plagiarism Screening"}},{"value":"2025-12-14","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-02-20","order":1,"name":"revised","label":"Revised","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-03-06","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-07-02","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}